Associate Professor, Medicine, Harvard Medical School
Nephrology
Dr. Anil K. Chandraker, MD
|
|
Give Review
Anil K. Chandraker, MD practices Nephrology. He has 2 awards "Secretary" and "Fellow (ASNF)". Anil Chandraker is a published physician. He published 100 publications, including: 'Chronic rejection from bedside to bench: role of T cells.' Dr. Anil K. Chandraker accepts Medicare payments and is registered with Medicare.gov.
Publications
- Recombinant PTH therapy for severe hypoparathyroidism after Kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case...
- Acute rejection in vascularized composite allotransplantation.
- Abstract 59: face transplantation in a highly sensitized recipient.
- Glomerular Inflammation Correlates With Endothelial Injury and With IL-6 and IL-1beta Secretion in the Peripheral Blood.
- Biomarker evaluation of face transplant rejection: association of donor T cells With target cell injury.
- Efficacy of Levofloxacin in the Treatment of BK Viremia: A Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial.
- Beyond calcineurin inhibitors: emerging agents in Kidney transplantation.
- Transplantation: A new molecular approach to the diagnosis of Acute rejection.
- The role of HCA2 (GPR109A) in regulating macrophage function.
- Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in Renal transplant r...
- Predictive biomarkers of renal allograft Failure.
- Jagged2-Signaling Promotes IL-6-dependent Transplant Rejection.
- VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients.
- Role of the PD-1 pathway in the Immune response.
- Dyslipidemia and its therapeutic challenges in Renal transplantation.
- Stem cell therapy in Kidney transplantation.
- The APOL1 genotype of African American Kidney transplant recipients does not impact 5-year allograft survival.
- Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following Renal transplantation.
- Derivation and Validation of a Cytokine-Based Assay to Screen for Acute Rejection in Renal Transplant Recipients.
- Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model.
- Impact of accidental discovery of Renal cell carcinoma at time of Renal transplantation on patient or graft survival.
- Blockade of Notch ligand delta1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation.
- Induction treatment with rabbit antithymocyte globulin versus basiliximab in Renal transplant recipients with planned early steroid withdrawal.
- Maintenance Immunosuppression with Intermittent Intravenous IL-2 Receptor Antibody Therapy in Renal Transplant Recipients (September).
- The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo.
- The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloImmune responses in vivo.
- Transitional cell carcinoma of the native urinary tract after Kidney transplantation: recommendations following a long-term retrospective analysis.
- Donor antigen-specific regulatory T-cell function affects outcome in Kidney transplant recipients.
- Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts.
- Hypophosphatemia in kidney transplant recipients: report of Acute phosphate nephropathy as a complication of therapy.
- Longitudinal trends and influence of BMI mismatch in living Kidney donors and their recipients.
- Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in Renal allograft recipients.
- Animal models of Chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction.
- Mortality among living Kidney donors and comparison populations.
- Evaluation of fluoroquinolones for the prevention of BK viremia after Renal transplantation.
- Analysis of infusion-site reactions in Renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximab.
- Quiz page May 2010: debilitating pain of the hands and feet following Kidney transplant.
- Paradoxical functions of B7: CD28 costimulation in a MHC class II-mismatched cardiac transplant model.
- Regulatory allospecific T cell clones abrogate Chronic allograft rejection.
- Report from a consensus conference on the sensitized patient awaiting Heart transplantation.
- New approaches for desensitization strategies prior to Kidney transplantation.
- Facial transplantation and immunosuppressed patients: a new frontier in reconstructive surgery.
- Care of the Kidney transplant recipient.
- Pottransplantation anemia: management and rationale.
- Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
- Differential inhibition of autoreactive memory- and alloreactive naive T cell Responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y.
- Invasive fungal infections and antifungal therapies in solid organ transplant recipients.
- Mechanisms and role of HLA and non-HLA alloantibodies.
- Induction therapy: are we picking our battles?
- Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.
- Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones.
- A J-shaped association between high-sensitivity C-reactive protein and mortality in Kidney transplant recipients.
- Transplant tolerance through costimulation blockade--are we there yet?
- Predialysis nephrologist care and access to Kidney transplantation in the United States.
- A prospective study of anaemia and long-term outcomes in Kidney transplant recipients.
- Does belatacept provide equivalent suppression of Acute renal transplant rejection to ciclosporin?
- BK viral reactivation in cardiac transplant patients: evidence for a double-hit hypothesis.
- Polyomavirus-associated Nephropathy: update on antiviral strategies.
- Modifying graft immunogenicity and Immune response prior to transplantation: potential clinical applications of donor and graft treatment.
- Angiotensin II type 1-receptor activating antibodies in Renal-allograft rejection.
- CTLA-4 is important in maintaining long-term survival of cardiac allografts.
- Fasting plasma total homocysteine levels and mortality and allograft loss in Kidney transplant recipients: a prospective study.
- Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus Disease in renal transplant recipients: a single-center, retrospective analysis.
- Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli.
- Pharmacoepidemiology of anemia in Kidney transplant recipients.
- The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction?
- Chronic rejection: insights from a novel immunosuppressive-free model of Kidney transplantation.
- A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric Renal transplant recipients.
- Interaction between ICOS-B7RP1 and B7-CD28 costimulatory pathways in alloImmune responses in vivo.
- The role of the CD134-CD134 ligand costimulatory pathway in alloImmune responses in vivo.
- Regulatory functions of alloreactive Th2 clones in human Renal transplant recipients.
- A novel CD154 monoclonal antibody in Acute and chronic rat vascularized cardiac allograft rejection.
- Mechanisms of targeting CD28 by a signaling monoclonal antibody in Acute and chronic allograft rejection.
- Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade.
- Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy.
- Hepatocyte growth factor prevents the development of Chronic allograft nephropathy in rats.
- Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo.
- CD28-B7-mediated T cell costimulation in Chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
- Human leukocyte antigen matching in Renal transplantation: an update.
- Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway.
- Role of passive T-cell death in Chronic experimental autoimmune encephalomyelitis.
- CD28-B7 blockade prevents the development of experimental autoimmune Glomerulonephritis.
- Diagnostic techniques in the work-up of Renal allograft dysfunction--an update.
- Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines.
- Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and toler...
- In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide.
- Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
- The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin.
- Ischemia-reperfusion injury in experimental models of organ transplantation.
- Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
- Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2.
- Role of peripheral clonal deletion in tolerance induction With bone marrow transplantation and costimulatory blockade.
- Chronic rejection from bedside to bench: role of T cells.
- Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) pep...
- Effects of explosive brain death on cytokine activation of peripheral organs in the rat.
- Comparative strategies to induce long-term graft acceptance in fully allogeneic Renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of...
- CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
- Extrathymic T cell deletion and allogeneic stem cell engraftment induced With costimulatory blockade is followed by central T cell tolerance.
- Late blockade of T cell costimulation interrupts progression of experimental Chronic allograft rejection.
Schools
University Of New South Wales Faculty Of Medicine
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Amyloidosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Simplifi
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Secretary
- Fellow (ASNF)
Education
-
Brigham and Women's Hospital -
University of Glasgow Faculty of Medicine
Hospital
-
Massachusetts General Hospital -
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1972569176 | |
| NPPES Provider LastName | CHANDRAKER | |
| NPPES Provider FirstName | ANIL | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1098.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1972569176 |
| Last Name Of The Provider | CHANDRAKER |
| First Name Of The Provider | ANIL |
| View All |
Similar Doctors
|
|
Dr. Wooin Ahn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meghan E. Sise, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shushrut S. Waikar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Finnian R. McCausland |
|
|
Dr. Mohammed J. Ansari, MD |
|
|
Dr. Didier Mandelbrot, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin R. Pollak, MD |
|
|
Dr. David J. Steele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omar H. Maarouf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kambiz Zandi-Nejad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Danziger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel E. Weiner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vipul C. Chitalia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roshan Sher Ali, MD
This Doctor is OpenDoctor Recommended.
|